Vitamin B3 Market Size and Share

Vitamin B3 Market Summary
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Vitamin B3 Market Analysis by Mordor Intelligence

The Vitamin B3 market size is USD 386.37 million in 2025 and is projected to reach USD 488.53 million by 2030 at a steady 4.27% CAGR. Growing fortification mandates, premium demand for cosmetics-grade niacinamide, and technological shifts toward bio-based synthesis are reshaping value pools within the Vitamin B3 market. Intensifying sustainability requirements are steering producers toward lower-carbon processes, while consumer interest in skin health and healthy aging is broadening application breadth. Oligopolistic supply structures continue to wield pricing power, yet dependence on a concentrated Chinese raw-material base exposes the Vitamin B3 market to regulatory shock. Companies that secure backward integration, geographic redundancy, and specialty-grade capabilities are positioned to capture margin upside.

Key Report Takeaways

  • By grade, Feed Grade captured 62.16% of the Vitamin B3 market share in 2024, followed by Cosmetics Grade, advancing at a 6.78% CAGR to 2030.
  • By form, Dry Form accounted for 74.31% of the Vitamin B3 market size in 2024, and Wet/Liquid Form is expanding at an 8.09% CAGR through 2030.
  • By application, Animal Nutrition held 60.28% of the Vitamin B3 market size in 2024, and Cosmetics applications are progressing at an 8.51% CAGR to 2030.
  • By geography, Asia-Pacific commanded a 40.41% share of the Vitamin B3 market in 2024 and is scaling at a 9.17% CAGR through 2030.

Segment Analysis

By Grade: Feed Applications Anchor Volume, Cosmetics Capture Value

In 2024, Feed Grade commands a dominant 62.16% share of the Vitamin B3 market, underscoring its pivotal role in global trade volumes. Regulatory dosing guidelines for livestock and the advantages of integrated premix operations ensure a steady flow, even amidst tight margins. With large contract volumes, plants maintain consistent utilization, allowing for cost absorption across diverse grade portfolios. However, as Feed Grade continues to be the dominant segment, it grapples with heightened competition from regional premix blenders and Asian SMEs, known for their low-cost, dry-blend operations. Consequently, major players are reallocating incremental capital expenditures towards cosmetics and pharmaceuticals, sectors where product differentiation is pronounced and regulatory challenges act as a barrier to entry for newcomers.

While Cosmetics Grade occupies a smaller tonnage segment, it boasts a robust 6.78% CAGR, contributing disproportionately to revenues due to average selling prices (ASPs) that far exceed those of feed counterparts. The surge in dermo-cosmetic product launches and over-the-counter skin serums, often featuring 5%-10% niacinamide concentrations, is driving this specialty demand. As Cosmetics Grade reshapes the earnings landscape of the Vitamin B3 market, brands are prioritizing traceability and purity. This heightened focus elevates standards for USP/BP-compliant production, steering preference towards suppliers adept in advanced crystallization and micronization techniques.

Vitamin B3 Market: Market Share by Grade
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

By Form: Dry Dominance Faces Liquid Innovation

Dry formulations, crystalline, powder, and granulated forms, hold 74.31% of the Vitamin B3 market size in 2024 because they integrate seamlessly into bulk premixes and fortified flour lines. Their low moisture and superior stability accommodate tropical warehousing and long transit times, making them the preferred choice for global commodity trading. Unit operations such as fluid-bed drying enable high throughput, keeping operating costs favorable for volume-driven applications. However, liquid niacinamide formulations are pacing 8.09% CAGR, capitalizing on precision-dose advantages and the elimination of dust hazards in cosmetics and pharma cleanrooms. The surge in water-based serums and leave-on skincare lines escalates liquid demand, reinforcing this shift.

Recent advances in nano-emulsion and encapsulation technologies reduce oxidation risk while improving skin penetration, further boosting liquid uptake. Feed-industry integrators experiment with liquid inclusion systems that improve homogeneity in micro-dosed rations, potentially bridging the gap between commodity and specialty domains. Yet, high transport costs for aqueous solutions and cold-chain requirements restrain broader substitution. Producers focus on modular plant designs that can toggle between dry spray granulation and wet crystallization, optimizing asset flexibility. The coexistence of both forms ensures the Vitamin B3 market maintains supply optionality while accommodating divergent performance specifications.

By Application: Animal Nutrition Leads, Cosmetics Accelerates

Animal Nutrition anchors 60.28% of the Vitamin B3 market size in 2024, reflecting its entrenched role in feed conversion optimization and disease mitigation in intensive livestock systems. Swine, poultry, and aqua feed formulators lock in contractual offtake volumes that underpin predictable baseline demand. Regulatory re-authorizations from EFSA and FDA reaffirm safety, sustaining inclusion across all commercial diets. Nonetheless, cosmetics applications outpace the aggregate market at 8.51% CAGR as beauty consumers prioritize clinically validated, multi-functional actives. Ingredient houses formulate high-purity niacinamide, sometimes co-encapsulated with ceramides, squeezing additional premium from the same molecule.

Human Nutrition/Dietary Supplements remain steady, buoyed by longevity research highlighting NAD+ precursors for metabolic resilience. Fortified bakery and cereal products ensure incremental but mandated niacin consumption; however, limited consumer visibility means pricing remains less elastic. Pharmaceutical and agrochemical uses persist as niche outlets, with the former leveraging nicotinamide’s anti-inflammatory properties and the latter employing it as an intermediate in crop protection agents. The diversified application spread insulates the Vitamin B3 market from singular demand shocks, though strategic emphasis is clearly shifting toward cosmetic and supplement adjacencies that promise margin expansion.

Vitamin B3 Market: Market Share by Application
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

Geography Analysis

Asia-Pacific commands 40.41% of the Vitamin B3 market and is accelerating at a 9.17% CAGR through 2030 as it balances world-scale manufacturing with rising domestic demand. China’s cost advantage remains compelling, but stringent VOC and wastewater standards trigger capacity rationalization, creating a supply-demand tightrope. India’s feed-grain and poultry sectors lift volumetric consumption, while Japan’s cosmeceutical ecosystem absorbs high-purity niacinamide for premium skincare lines. Emerging ASEAN economies institute wheat-flour fortification programs, injecting incremental volume into the regional Vitamin B3 market.

North America exhibits mature but resilient demand backed by robust regulatory frameworks such as GRAS status and explicit fortification directives. Re-shoring initiatives spur feasibility analyses for domestic pyridine and niacin plants, yet capital intensity keeps most projects at the concept stage. The United States and Canada drive specialty-grade growth in dermo-cosmetic and pet-nutrition channels, cushioning flat feed tonnage. Mexico benefits from rising pork production and fortified-flour mandates, modestly expanding regional volume.

Europe foregrounds sustainability, propelling interest in bio-catalytic processes and plant-based feedstocks. Germany’s BfR recently capped daily supplemental nicotinamide at 160 mg, signaling continued consumer-safety vigilance. Cosmetic-grade demand thrives in France and Italy’s dermo-pharmacy segment, while companion-animal premiumization opens new distribution avenues. Eastern Europe’s intensified poultry complexes adopt precision-feed systems, boosting feed-grade consumption. South America and the Middle East & Africa trail in absolute volume but unlock upside through urbanization and government-led fortification campaigns, giving the Vitamin B3 market an expanding geographic footprint.

Vitamin B3 Market CAGR (%), Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Get Analysis on Important Geographic Markets
Download PDF

Competitive Landscape

Global supply, scoring 8/10 on the concentration scale, sees DSM-Firmenich, Lonza, and Jubilant Ingrevia wielding significant influence through their capacity, technology, and customer ties. Amid ongoing pricing pressures, DSM-Firmenich is rationalizing its vitamin portfolio—closing select assets in China and fine-tuning its premix networks—to bolster returns. Lonza, through its “One Lonza” initiative, is shifting away from lower-margin capsule operations, redirecting capital towards CDMO and high-value biosynthesis, underscoring a trend of portfolio refinement. 

Meanwhile, Jubilant Ingrevia is capitalizing on its cost-effective operations in India to delve into cosmetics-grade markets, recently debuting ultra-low-residual solvents niacinamide, tailored for K-beauty brands. By vertically integrating, companies secure vital pyridine intermediates, and with plants spread across two continents, they effectively counter regional disruptions. Instead of radical molecule redesigns, the focus on technology differentiation leans towards yield optimization, effluent reduction, and impurity control, highlighting a shift from commodity to specialty. 

Collaborating with biotech start-ups, firms are fast-tracking their entry into microbial niacin pathways, providing a buffer against potential environmental restrictions on petrochemical methods. While the stringent regulations in the Vitamin B3 market pose challenges for new entrants, established players grapple with shrinking margins unless they transition towards specialty grades and adopt ESG-compliant manufacturing practices.

Vitamin B3 Industry Leaders

  1. DSM-Firmenich

  2. Lonza Group AG

  3. Jubilant Ingrevia Ltd.

  4. Brother Enterprises Holding

  5. Lasons India Pvt Ltd.

  6. *Disclaimer: Major Players sorted in no particular order
Vitamin B3 Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • January 2025: Jubilant Ingrevia has announced the commissioning of its new cGMP compliant facility at Bharuch, Gujarat. The new facility, which has a capacity of 5,000 metric tonnes, will manufacture nutraceuticals and dietary-active ingredients for human consumption.
  • October 2024: BASF declared Force Majeure for selected vitamin A, vitamin E, and carotenoid products following a fire at its Ludwigshafen plant, leading to supply disruptions that may affect the broader vitamin market dynamics.

Table of Contents for Vitamin B3 Industry Report

1. Introduction

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Surging demand for fortified F&B
    • 4.2.2 Feed-industry vitamin premix boom
    • 4.2.3 Cosmetics shift to niacinamide actives
    • 4.2.4 Bio-based, lower-carbon synthesis routes
    • 4.2.5 Companion-animal cardiometabolic health demand
    • 4.2.6 US/EU re-shoring of vitamin supply
  • 4.3 Market Restraints
    • 4.3.1 Raw-material & price volatility
    • 4.3.2 China environmental crack-downs on pyridine
    • 4.3.3 Whole-food nutrition preference
    • 4.3.4 Legacy cartel scrutiny and compliance costs
  • 4.4 Value/Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Porter's Five Forces
    • 4.6.1 Bargaining Power of Suppliers
    • 4.6.2 Bargaining Power of Buyers
    • 4.6.3 Threat of Substitutes
    • 4.6.4 Threat of New Entrants
    • 4.6.5 Competitive Rivalry

5. Market Size & Growth Forecasts (Value and Volume)

  • 5.1 By Grade
    • 5.1.1 Feed Grade
    • 5.1.2 Food Grade
    • 5.1.3 Cosmetics Grade
    • 5.1.4 Others (Pharmaceutical Grade)
  • 5.2 Form
    • 5.2.1 Dry
    • 5.2.2 Wet
  • 5.3 Application
    • 5.3.1 Animal Nutrition
    • 5.3.2 Human Nutrition/Dietary Supplements
    • 5.3.3 Food and Beverage Fortification
    • 5.3.4 Cosmetics
    • 5.3.5 Others (Pharmaceutical Industry, AgroChemicals)
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.1.4 Rest of North America
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 Italy
    • 5.4.2.4 France
    • 5.4.2.5 Spain
    • 5.4.2.6 Netherlands
    • 5.4.2.7 Russia
    • 5.4.2.8 Belgium
    • 5.4.2.9 Sweden
    • 5.4.2.10 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 India
    • 5.4.3.3 Japan
    • 5.4.3.4 Australia
    • 5.4.3.5 Indonesia
    • 5.4.3.6 South Korea
    • 5.4.3.7 Thailand
    • 5.4.3.8 Singapore
    • 5.4.3.9 Rest of Asia-Pacific
    • 5.4.4 South America
    • 5.4.4.1 Brazil
    • 5.4.4.2 Argentina
    • 5.4.4.3 Chile
    • 5.4.4.4 Peru
    • 5.4.4.5 Rest of South America
    • 5.4.5 Middle East and Africa
    • 5.4.5.1 South Africa
    • 5.4.5.2 Saudi Arabia
    • 5.4.5.3 United Arab Emirates
    • 5.4.5.4 Nigeria
    • 5.4.5.5 Egypt
    • 5.4.5.6 Iran
    • 5.4.5.7 Turkey
    • 5.4.5.8 Rest of Middle East and Africa

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Strategic Moves
  • 6.3 Market Share Analysis
  • 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.4.1 DSM-Firmenich
    • 6.4.2 Lonza Group AG
    • 6.4.3 Jubilant Ingrevia Ltd.
    • 6.4.4 Brother Enterprises Holding
    • 6.4.5 Lasons India Pvt Ltd.
    • 6.4.6 Zhejiang NHU Co., Ltd.
    • 6.4.7 Vertellus Holdings
    • 6.4.8 Vanetta Ltd.
    • 6.4.9 BASF SE
    • 6.4.10 Evonik Industries AG
    • 6.4.11 Glanbia Nutritionals
    • 6.4.12 Foodchem International
    • 6.4.13 Actylis
    • 6.4.14 Sabinsa Corporation
    • 6.4.15 AIE Pharmaceuticals
    • 6.4.16 BulkSupplements.com
    • 6.4.17 Spectrum Chemical
    • 6.4.18 PCCA Inc.
    • 6.4.19 V N Life Sciences
    • 6.4.20 Zhejiang Medicine Co.

7. Market Opportunities and Future Outlook

You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Vitamin B3 Market Report Scope

By Grade
Feed Grade
Food Grade
Cosmetics Grade
Others (Pharmaceutical Grade)
Form
Dry
Wet
Application
Animal Nutrition
Human Nutrition/Dietary Supplements
Food and Beverage Fortification
Cosmetics
Others (Pharmaceutical Industry, AgroChemicals)
Geography
North America United States
Canada
Mexico
Rest of North America
Europe Germany
United Kingdom
Italy
France
Spain
Netherlands
Russia
Belgium
Sweden
Rest of Europe
Asia-Pacific China
India
Japan
Australia
Indonesia
South Korea
Thailand
Singapore
Rest of Asia-Pacific
South America Brazil
Argentina
Chile
Peru
Rest of South America
Middle East and Africa South Africa
Saudi Arabia
United Arab Emirates
Nigeria
Egypt
Iran
Turkey
Rest of Middle East and Africa
By Grade Feed Grade
Food Grade
Cosmetics Grade
Others (Pharmaceutical Grade)
Form Dry
Wet
Application Animal Nutrition
Human Nutrition/Dietary Supplements
Food and Beverage Fortification
Cosmetics
Others (Pharmaceutical Industry, AgroChemicals)
Geography North America United States
Canada
Mexico
Rest of North America
Europe Germany
United Kingdom
Italy
France
Spain
Netherlands
Russia
Belgium
Sweden
Rest of Europe
Asia-Pacific China
India
Japan
Australia
Indonesia
South Korea
Thailand
Singapore
Rest of Asia-Pacific
South America Brazil
Argentina
Chile
Peru
Rest of South America
Middle East and Africa South Africa
Saudi Arabia
United Arab Emirates
Nigeria
Egypt
Iran
Turkey
Rest of Middle East and Africa
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the current size and growth outlook for the Vitamin B3 market?

The Vitamin B3 market stands at USD 386.37 million in 2025 and is forecast to reach USD 488.53 million by 2030, posting a 4.27% CAGR.

Which segment is expanding fastest within the Vitamin B3 landscape?

Cosmetics-grade niacinamide is the fastest-growing segment, advancing at a 6.78% CAGR through 2030 as skincare brands embrace science-backed actives.

How concentrated is global Vitamin B3 supply?

The market scores 8/10 for concentration, with DSM-Firmenich, Lonza, and Jubilant Ingrevia controlling well over 80% of installed capacity.

Why is Asia-Pacific pivotal to Vitamin B3 trade flows?

Asia-Pacific represents 40.41% of global demand and houses the bulk of pyridine-based manufacturing, making it both the key production hub and fastest-growing consumption region.

What are the main supply-side risks facing Vitamin B3 buyers?

Environmental crack-downs on Chinese pyridine plants and feedstock price volatility can disrupt supply and elevate costs in the short to medium term.

What strategic moves can buyers take to mitigate supply risk?

Diversifying sourcing, locking in long-term contracts with vertically integrated producers, and evaluating bio-based suppliers can reduce exposure to raw-material shocks.

Page last updated on: